Gurrera RJ (2002). “Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?”. Clinical Neuropharmacology25 (4): 183-93. PMID12151905.
Araki M, Takagi A, Higuchi I, Sugita H (1988). “Neuroleptic malignant syndrome: caffeine contracture of single muscle fibers and muscle pathology”. Neurology38 (2): 297-301. PMID3340297.
Sato T, Nishio H, Iwata M, Kentotsuboi, Tamura A, Miyazaki T, Suzuki K (2010). “Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome”. Forensic Sci Int.194 (1-3): 77-9. PMID19931341.